Microtubule-associated protein 2 (MAP2) and c-fos expression in the rat prefrontal cortex following subchronic treatment with substituted amphetamines.
Spina
M G
MG
Institute of Medical Neurobiology, University of Magdeburg, Germany. mariarosa.spina@medizin.uni-magdeburg.de
Grecksch
G
G
Kovar
K A
KA
Wolf
G
G
Putzke
J
J
D000661:Amphetamine / Q000008:administration & dosage*; D000818:Animals; D001345:Autoradiography / Q000379:methods; D015152:Blotting, Northern / Q000379:methods; D000697:Central Nervous System Stimulants / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005786:Gene Expression Regulation / Q000187:drug effects*; D008297:Male; D008694:Methamphetamine / Q000008:administration & dosage; D008869:Microtubule-Associated Proteins / Q000235:genetics / Q000378:metabolism*; D017397:Prefrontal Cortex / Q000187:drug effects*; D016760:Proto-Oncogene Proteins c-fos / Q000235:genetics / Q000378:metabolism*; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D018490:Serotonin Agents / Q000008:administration & dosage; D010133:p-Chloroamphetamine / Q000008:administration & dosage
D000697:Central Nervous System Stimulants; C489787:MAP2 protein, rat; D008869:Microtubule-Associated Proteins; D016760:Proto-Oncogene Proteins c-fos; D012333:RNA, Messenger; D018490:Serotonin Agents; D008694:Methamphetamine; D010133:p-Chloroamphetamine; D000661:Amphetamine